Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Nat Immunol. 2014 May;15(5):449-56. doi: 10.1038/ni.2863. Epub 2014 Mar 30.

The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Author information

1
Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan.
2
1] Department of Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan. [2] Department of Biochemistry, Toho University School of Medicine, Tokyo, Japan.
3
Division of Immune Regulation, La Jolla Institute, La Jolla, California, USA.

Abstract

The physiological functions of members of the tumor-necrosis factor (TNF) receptor (TNFR)-associated factor (TRAF) family in T cell immunity are not well understood. We found that in the presence of interleukin 6 (IL-6), naive TRAF5-deficient CD4(+) T cells showed an enhanced ability to differentiate into the TH17 subset of helper T cells. Accordingly, TH17 cell-associated experimental autoimmune encephalomyelitis (EAE) was greatly exaggerated in Traf5(-/-) mice. Although it is normally linked with TNFR signaling pathways, TRAF5 constitutively associated with a cytoplasmic region in the signal-transducing receptor gp130 that overlaps with the binding site for the transcription activator STAT3 and suppressed the recruitment and activation of STAT3 in response to IL-6. Our results identify TRAF5 as a negative regulator of the IL-6 receptor signaling pathway that limits the induction of proinflammatory CD4(+) T cells that require IL-6 for their development.

PMID:
24681564
PMCID:
PMC4108451
DOI:
10.1038/ni.2863
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center